# Investigating the Effects of Lipid-therapy Intensification With Alirocumab on Endothelial Function, Carotid Arteries, Lipoprotein Particle Subfractions, Inflammation and Post-prandial Lipemia

> **NCT03559309** · PHASE4 · TERMINATED · sponsor: **Medical University of Graz** · enrollment: 24 (actual)

## Conditions studied

- Atherosclerosis
- Hypercholesterolemia
- Post Prandial Lipemia
- Cardiovascular Diseases

## Interventions

- **DIAGNOSTIC_TEST:** Magnet Resonance Tomography, Carotid Arteries Sonography, Flow-mediated Dilation, Fat-tolerance Test, Laboratory Testing

## Key facts

- **NCT ID:** NCT03559309
- **Lead sponsor:** Medical University of Graz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-06-20
- **Primary completion:** 2020-02-05
- **Final completion:** 2020-02-05
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** COVID-19 Pandemic Measures
- **Last updated:** 2020-04-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03559309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03559309, "Investigating the Effects of Lipid-therapy Intensification With Alirocumab on Endothelial Function, Carotid Arteries, Lipoprotein Particle Subfractions, Inflammation and Post-prandial Lipemia". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT03559309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*